Role of the alpha 5 beta 1 integrin receptor in the proliferative response of quiescent human melanoma cells to fibronectin
- PMID: 1386557
Role of the alpha 5 beta 1 integrin receptor in the proliferative response of quiescent human melanoma cells to fibronectin
Abstract
The possible mitogenic activity of fibronectin (FN) in human primary and metastatic melanoma lines and clones and the involvement of integrins in mediating this effect were evaluated. Quescent human melanoma cells cultured in serum-free medium proliferated in a dose- and time-dependent fashion to immobilized FN as indicated by [3H]thymidine incorporation, increment of cell number, and cell cycle analysis. This response to FN was observed with tumor clones isolated from a subcutaneous metastasis and with primary or metastatic melanomas from different patients, but only when tumor cells expressed the alpha 5 subunit of the FN receptor (i.e., VLA-5). Proliferation to FN by a primary tumor (Me4405) expressing all FN receptors and by a tumor clone (2/60) lacking only the alpha 4 subunit was inhibited by monoclonal antibodies to the alpha 5 and beta 1 but not by monoclonal antibodies to other subunits of FN receptors. Mapping of FN regions responsible for the proliferative signal was performed by stimulating melanoma cells with different FN proteolytic fragments and indicated that a significant mitogenic signal was provided by the M(r) 120,000 alpha-chymotrypsin fragment containing the Arg-Gly-Asp sequence. The proliferation of melanoma cells to FN and to FN fragments was also significantly inhibited by peptides containing the Arg-Gly-Asp sequence. These data indicate that FN can stimulate the proliferation of quiescent melanoma cells and that integrins as alpha 5 beta 1 are involved in the response of tumor cells to this extracellular matrix protein.
Similar articles
-
Mitogenic activity of laminin on human melanoma and melanocytes: different signal requirements and role of beta 1 integrins.Cancer Res. 1995 Oct 15;55(20):4702-10. Cancer Res. 1995. PMID: 7553652
-
The novel recognition site in the C-terminal heparin-binding domain of fibronectin by integrin alpha 4 beta 1 receptor on HL-60 cells.Exp Cell Res. 1996 Feb 1;222(2):326-32. doi: 10.1006/excr.1996.0042. Exp Cell Res. 1996. PMID: 8598221
-
Signaling via CD7 molecules on human NK cells. Induction of tyrosine phosphorylation and beta 1 integrin-mediated adhesion to fibronectin.J Immunol. 1994 Oct 15;153(8):3504-13. J Immunol. 1994. PMID: 7523496
-
IFN-gamma and transforming growth factor-beta 1 differently regulate fibronectin and laminin receptors of human differentiating monocytic cells.J Immunol. 1992 Jun 15;148(12):3912-9. J Immunol. 1992. PMID: 1534826
-
Structure, function and biological properties of integrin alpha v beta 3 on human melanoma cells.Cancer Metastasis Rev. 1991 May;10(1):3-10. doi: 10.1007/BF00046839. Cancer Metastasis Rev. 1991. PMID: 1717171 Review.
Cited by
-
Signal transduction by integrins and its role in the regulation of tumor growth.Cancer Metastasis Rev. 1994 Mar;13(1):25-30. doi: 10.1007/BF00690416. Cancer Metastasis Rev. 1994. PMID: 8143343 Review.
-
Metastatic potential of human melanoma cells in nude mice--characterisation of phenotype, cytokine secretion and tumour-associated antigens.Br J Cancer. 1996 Jul;74(2):194-9. doi: 10.1038/bjc.1996.337. Br J Cancer. 1996. PMID: 8688321 Free PMC article.
-
Induction of nonspecific cross-reacting antigen mRNA by interferon-gamma and anti-fibronectin receptor antibody in colon cancer cells.J Gastroenterol. 1997 Apr;32(2):200-5. doi: 10.1007/BF02936368. J Gastroenterol. 1997. PMID: 9085168
-
Extracellular Matrix as a Target in Melanoma Therapy: From Hypothesis to Clinical Trials.Cells. 2024 Nov 19;13(22):1917. doi: 10.3390/cells13221917. Cells. 2024. PMID: 39594665 Free PMC article. Review.
-
Integrin alpha5beta1: a potent inhibitor of experimental lung metastasis.Clin Exp Metastasis. 1998 Jul;16(5):427-35. doi: 10.1023/a:1006581424490. Clin Exp Metastasis. 1998. PMID: 10091938
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous